Cell hybridization, hybridomas, and human hybridomas
- PMID: 9648102
- DOI: 10.1016/s0091-679x(08)61575-7
Cell hybridization, hybridomas, and human hybridomas
Abstract
Cell hybridization is one of the most basic cytotechnologies. The hemagglutinating virus of Japan was first used to cause cell fusion; however, polyethylene glycol is widely used now because of simplicity of procedure. This chapter first explains the principles of cell hybridization methods and then describes the practical protocols for preparing mouse hybridomas using polyethylene glycol. So far, lack of an excellent human fusion partner cell line that has high fusion efficiencies and does not produce immunoglobulin has hindered the spread of human-human hybridoma preparation methods. In the authors' laboratory NAT-30 and HO-323, human parent cell lines with high fusion efficiencies, have been established to prepare many hybridoma cell lines producing cancer-specific human monoclonal antibodies. Because NAT-30 and HO-323 cell lines are IgM producers, it is difficult to obtain IgG-producing hybridomas because the types of immunoglobulin produced by hybridomas are strongly affected by the characteristics of parent cells. Thus a nonimmunoglobulin-producing human parent cell line, A4H12, derived from human T lymphoma was established that can efficiently obtain IgG-producing human hybridomas. Another problem with preparing human hybridomas is that it is difficult to obtain B lymphocytes immunized with optional antigens for ethical reasons. To overcome this problem, in vitro immunization methods have been developed that allow exposure of a large number of B lymphocytes to cultured cancer cell or soluble antigens. The section on human hybridomas explains human fusion partners, in vitro immunization methods, and the preparation of human-human hybridomas using an electrofusion method. Finally, the application of human monoclonal antibodies to medical uses and the preparation of supranatural monoclonal antibodies are reviewed. These include multifunctional monoclonal antibodies and altered monoclonal antibodies having increased affinity and specificity by exchanging or modifying light chains.
Similar articles
-
[Attempts to improve hybridoma technology for the production of human monoclonal antibodies].Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):2198-204. Gan To Kagaku Ryoho. 1987. PMID: 3038035 Japanese.
-
[Monoclonal antibodies produced by human-human hybridomas].Gan To Kagaku Ryoho. 1984 Jan;11(1):157-64. Gan To Kagaku Ryoho. 1984. PMID: 6607711 Japanese.
-
A new human fusion partner, HK-128, for making human-human hybridomas producing monoclonal IgG antibodies.Cytotechnology. 1990 Sep;4(2):139-43. doi: 10.1007/BF00365094. Cytotechnology. 1990. PMID: 1367041
-
Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.Cancer Metastasis Rev. 1984;3(1):5-24. doi: 10.1007/BF00047690. Cancer Metastasis Rev. 1984. PMID: 6370419 Review.
-
Human monoclonal antibodies: methods of production and some aspects of their application in oncology.Med Oncol Tumor Pharmacother. 1984;1(4):235-46. doi: 10.1007/BF02934529. Med Oncol Tumor Pharmacother. 1984. PMID: 6400038 Review.
Cited by
-
A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.Br J Haematol. 2016 Nov;175(4):724-732. doi: 10.1111/bjh.14298. Epub 2016 Sep 8. Br J Haematol. 2016. PMID: 27605462 Free PMC article.
-
Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody.PLoS One. 2013 Oct 16;8(10):e77892. doi: 10.1371/journal.pone.0077892. eCollection 2013. PLoS One. 2013. PMID: 24147093 Free PMC article.
-
Human monoclonal antibodies broadly neutralizing against influenza B virus.PLoS Pathog. 2013 Feb;9(2):e1003150. doi: 10.1371/journal.ppat.1003150. Epub 2013 Feb 7. PLoS Pathog. 2013. PMID: 23408886 Free PMC article.
-
Creation of a biological pacemaker by gene- or cell-based approaches.Med Biol Eng Comput. 2007 Feb;45(2):133-44. doi: 10.1007/s11517-007-0165-2. Epub 2007 Jan 30. Med Biol Eng Comput. 2007. PMID: 17262203 Review.
-
Gene Therapy for Cardiac Arrhythmias.Acta Cardiol Sin. 2013 May;29(3):226-34. Acta Cardiol Sin. 2013. PMID: 27122711 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources